DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,914,927 | +3.4% | 11,749 | 0.0% | 0.78% | +8.6% |
| Q2 2023 | $2,819,760 | -9.3% | 11,749 | -4.7% | 0.72% | -9.4% |
| Q1 2023 | $3,108,398 | -5.4% | 12,333 | -0.4% | 0.80% | -9.8% |
| Q4 2022 | $3,286,595 | +2.0% | 12,383 | -0.8% | 0.88% | -4.5% |
| Q3 2022 | $3,223,000 | +0.2% | 12,477 | -1.7% | 0.92% | +5.1% |
| Q2 2022 | $3,217,000 | -15.8% | 12,690 | -2.6% | 0.88% | -3.5% |
| Q1 2022 | $3,822,000 | -14.5% | 13,030 | -4.0% | 0.91% | -9.7% |
| Q4 2021 | $4,468,000 | +7.2% | 13,579 | -0.8% | 1.01% | -0.6% |
| Q3 2021 | $4,167,000 | +2.2% | 13,688 | -9.9% | 1.02% | +2.9% |
| Q2 2021 | $4,077,000 | +15.5% | 15,194 | -3.1% | 0.99% | +9.3% |
| Q1 2021 | $3,529,000 | +1.5% | 15,679 | +0.2% | 0.90% | -3.6% |
| Q4 2020 | $3,477,000 | +2.2% | 15,653 | -0.9% | 0.94% | -6.6% |
| Q3 2020 | $3,403,000 | +21.7% | 15,803 | -0.1% | 1.00% | +14.4% |
| Q2 2020 | $2,797,000 | +26.0% | 15,818 | -1.4% | 0.88% | +8.3% |
| Q1 2020 | $2,220,000 | -17.2% | 16,038 | -8.2% | 0.81% | -1.1% |
| Q4 2019 | $2,680,000 | +3.2% | 17,463 | -2.9% | 0.82% | -4.4% |
| Q3 2019 | $2,596,000 | -0.6% | 17,977 | -1.6% | 0.86% | -0.7% |
| Q2 2019 | $2,612,000 | +5.2% | 18,277 | -2.8% | 0.86% | +2.0% |
| Q1 2019 | $2,482,000 | +24.1% | 18,801 | -3.0% | 0.84% | +13.6% |
| Q4 2018 | $2,000,000 | -3.3% | 19,391 | +1.9% | 0.74% | +6.6% |
| Q3 2018 | $2,068,000 | +6.2% | 19,035 | -3.6% | 0.70% | +1.3% |
| Q2 2018 | $1,948,000 | +0.8% | 19,745 | +0.0% | 0.69% | -0.6% |
| Q1 2018 | $1,933,000 | +14.2% | 19,744 | +8.3% | 0.69% | +13.4% |
| Q4 2017 | $1,692,000 | -1.1% | 18,233 | -8.5% | 0.61% | -7.1% |
| Q3 2017 | $1,710,000 | +1.2% | 19,932 | -0.5% | 0.66% | -3.7% |
| Q2 2017 | $1,690,000 | -5.2% | 20,031 | -3.8% | 0.68% | -7.1% |
| Q1 2017 | $1,782,000 | +9.1% | 20,830 | -0.7% | 0.74% | +1.8% |
| Q4 2016 | $1,633,000 | +1.2% | 20,979 | +1.9% | 0.72% | +1.1% |
| Q3 2016 | $1,613,000 | -23.1% | 20,578 | -1.0% | 0.71% | -25.5% |
| Q2 2016 | $2,098,000 | +5.7% | 20,776 | -0.7% | 0.96% | +4.1% |
| Q1 2016 | $1,985,000 | -2.1% | 20,925 | -4.1% | 0.92% | -19.8% |
| Q4 2015 | $2,027,000 | -4.7% | 21,825 | -12.6% | 1.15% | -8.5% |
| Q3 2015 | $2,127,000 | -3.1% | 24,960 | -2.7% | 1.26% | +1.5% |
| Q2 2015 | $2,196,000 | +0.8% | 25,660 | 0.0% | 1.24% | -2.2% |
| Q1 2015 | $2,179,000 | -2.5% | 25,660 | -1.5% | 1.26% | -7.4% |
| Q4 2014 | $2,234,000 | – | 26,060 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |